ArticleCancer causes & control : CCC2019
Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
Article in Cancer causes & control : CCC, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment.Applied health economics and health policy · 2026Pooled it
- Predicting factors for breast cancer screening in Middle Eastern women based on health belief model: a systematic review.Journal of the Egyptian National Cancer Institute · 2022Pooled it
- Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Pooled it
- "Clicks, likes, shares and comments" a systematic review of breast cancer screening discourse in social media.PloS one · 2020Pooled it
- Integrated Community-Clinic Model of Optimized Implementation Strategies to Increase Early Detection of Breast and Cervical Cancers in Kenya: Protocol for a Pragmatic Randomized Controlled Trial.JMIR research protocols · 2026Article
- Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years.JAMA network open · 2026Article
- Cost-Effectiveness of Breast Cancer Screening Using Digital Mammography in Canada.JAMA network open · 2025Article
- Choosing the right artificial intelligence solutions for your radiology department: key factors to considerDiagnostic and interventional radiology (Ankara, Turkey) · 2024Review
- Evolving Concepts in Helicobacter pylori Management.Gastroenterology · 2024Review
- Transgender preventative health-chest/breast cancer screening.Frontiers in health services · 2024Article
- Improving Health Equity in Adherence to Diagnostic Breast Imaging Workup Recommendations.Journal of the American College of Radiology : JACR · 2022Article
- Determinants of Protective Healthcare Services Awareness among Female Syrian Refugees in Turkey.Healthcare (Basel, Switzerland) · 2022Article
- Qualitative factors influencing breast and cervical cancer screening in women: A scoping review.Preventive medicine reports · 2022Article
- COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.Academic radiology · 2022Article
- Article
- Cost-Effectiveness of Breast Cancer Screening in Shiraz, Iran.International journal of preventive medicine · 2022Article
- Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.Academic radiology · 2022Article
- Relationship between insurance status and outcomes for patients with breast cancer in Missouri.Cancer · 2021Article
- Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?European journal of cancer (Oxford, England : 1990) · 2020Article
- Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.Cancer causes & control : CCC · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo estimate the cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
methodsUsing a modified CISNET breast cancer simulation model, we estimated outcomes for women aged 40-64 years associated with three scenarios: breast cancer screening within the NBCCEDP, screening in the absence of the NBCCEDP (no program), and no screening through any program. We report screening outcomes, cost, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), and sensitivity analyses results.
resultsCompared with no program and no screening, the NBCCEDP lowers breast cancer mortality and improves QALYs, but raises health care costs. Base-case ICER for the program was $51,754/QALY versus no program and $50,223/QALY versus no screening. Probabilistic sensitivity analysis ICER for the program was $56,615/QALY [95% CI $24,069, $134,230/QALY] versus no program and $51,096/QALY gained [95% CI $26,423, $97,315/QALY] versus no screening.
conclusionsOn average, breast cancer screening in the NBCCEDP was cost-effective compared with no program or no screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.